1. Halozyme Therapeutics Inc.
  2. Halozyme Therapeutics Inc. Ownership

Historical shareholding details of Hussman Strategic Advisors Inc holdings in Halozyme Therapeutics Inc. (HALO)

Monthly changes of Hussman Strategic Advisors Inc shareholding in Halozyme Therapeutics Inc. over the previous months

Month Name Total no. shares held Percent Holding
Aug 31, 2025 Hussman Strategic Advisors Inc 84,000 0.07%
Jul 31, 2025 Hussman Strategic Advisors Inc 73,500 0.06%
Jun 30, 2025 Hussman Strategic Advisors Inc 84,000 0.07%
Jun 30, 2025 Hussman Strategic Advisors Inc 73,500 0.06%
May 31, 2025 Hussman Strategic Advisors Inc 73,500 0.06%
Apr 30, 2025 Hussman Strategic Advisors Inc 73,500 0.06%
Mar 31, 2025 Hussman Strategic Advisors Inc 73,500 0.06%
Mar 31, 2025 Hussman Strategic Advisors Inc 73,500 0.06%
Feb 28, 2025 Hussman Strategic Advisors Inc 72,000 0.06%
Jan 31, 2025 Hussman Strategic Advisors Inc 42,000 0.03%
Dec 31, 2024 Hussman Strategic Advisors Inc 73,500 0.06%
Dec 31, 2024 Hussman Strategic Advisors Inc 42,000 0.03%
Nov 30, 2024 Hussman Strategic Advisors Inc 42,000 0.03%
Oct 31, 2024 Hussman Strategic Advisors Inc 41,500 0.03%
Sep 30, 2024 Hussman Strategic Advisors Inc 42,000 0.03%
Sep 30, 2024 Hussman Strategic Advisors Inc 31,500 0.02%
Aug 31, 2024 Hussman Strategic Advisors Inc 31,500 0.02%
Jul 31, 2024 Hussman Strategic Advisors Inc 31,500 0.02%
Jun 30, 2024 Hussman Strategic Advisors Inc 42,000 0.03%
Jun 30, 2024 Hussman Strategic Advisors Inc 31,500 0.02%
May 31, 2024 Hussman Strategic Advisors Inc 31,500 0.02%
Apr 30, 2024 Hussman Strategic Advisors Inc 31,500 0.02%
Mar 31, 2024 Hussman Strategic Advisors Inc 31,500 0.02%
Mar 31, 2024 Hussman Strategic Advisors Inc 31,500 0.02%
Feb 29, 2024 Hussman Strategic Advisors Inc 31,500 0.02%
Jan 31, 2024 Hussman Strategic Advisors Inc 31,500 0.02%
Dec 31, 2023 Hussman Strategic Advisors Inc 31,500 0.02%
Dec 31, 2023 Hussman Strategic Advisors Inc 31,500 0.02%
Nov 30, 2023 Hussman Strategic Advisors Inc 31,500 0.02%
Oct 31, 2023 Hussman Strategic Advisors Inc 46,500 0.04%
Sep 30, 2023 Hussman Strategic Advisors Inc 31,500 0.02%
Sep 30, 2023 Hussman Strategic Advisors Inc 46,500 0.04%
Aug 31, 2023 Hussman Strategic Advisors Inc 46,500 0.04%
Jul 31, 2023 Hussman Strategic Advisors Inc 46,500 0.04%
Jun 30, 2023 Hussman Strategic Advisors Inc 46,500 0.04%
Jun 30, 2023 Hussman Strategic Advisors Inc 46,500 0.04%
May 31, 2023 Hussman Strategic Advisors Inc 46,500 0.04%
Mar 31, 2023 Hussman Strategic Advisors Inc 46,500 0.04%

View all ownership details of Halozyme Therapeutics Inc.